Skip to content
Open access

Development and clinical validation of an artificial intelligence based model for thyroid nodule malignancy risk assessment using C-TIRADS guidelines

Jul 2026 · Frontiers in Medicine · Vol 13 · 0 citations · 37 references
Medicine

TL;DR

The proposed C-TIRADS-guided framework can localize thyroid nodules, classify guideline-defined ultrasound features, and provide standardized malignancy risk stratification and may assist physicians in thyroid ultrasound interpretation.

Abstract

Background Thyroid nodules refer to discrete lesions within the thyroid gland, caused by abnormal proliferation of thyroid cells and local growth. Thyroid ultrasound imaging is a non-invasive, widely used technique primarily employed to assess the benign or malignant nature of nodules, the extent of invasion into adjacent tissues, and lymph node metastasis. Early ultrasound diagnosis can help reduce the incidence of thyroid cancer. However, the diagnostic results from ultrasound examinations are often subjective, labor-intensive, and highly dependent on the clinical experience of the ultrasound physician. Methods We developed a C-TIRADS-guided computer-aided diagnostic framework consisting of a nodule detection module, a C-TIRADS feature classification module, and a rule-based risk scoring module. Thyroid nodules were first localized using the detection network and then classified according to key C-TIRADS ultrasound features, including composition, echogenicity, margin, shape, and echogenic foci. The predicted feature scores were aggregated to determine the benign or malignant risk category. The model was trained using task-specific datasets and clinically validated on an independent cohort of 303 thyroid nodules/images from 284 patients. Results In the independent clinical validation set, the AI model achieved an overall accuracy of 0.862 [95% CI, 0.822–0.901]. Physician accuracy was 0.705 [95% CI, 0.657–0.756] without AI assistance and increased to 0.845 [95% CI, 0.802–0.884] with AI assistance. These findings suggest the potential value of the proposed system as a C-TIRADS-guided decision-support tool. Conclusion The proposed C-TIRADS-guided framework can localize thyroid nodules, classify guideline-defined ultrasound features, and provide standardized malignancy risk stratification. The model may assist physicians in thyroid ultrasound interpretation; however, larger blinded multicenter studies are required before routine clinical application.

Read PDF

Similar papers

Open access Aug 2026

Clinical value of artificial intelligence ultrasound-assisted diagnostic system in the differential diagnosis of benign and malignant thyroid nodules

The AI-UADS demonstrates good diagnostic performance in differentiating BTNs and MTNs, and can serve as an effective auxiliary tool for ultrasonographers, showing particular advantages in diagnosing nodules with a maximum diameter, located in the left lobe, far from the capsule, and in patients without HT.

Meng Tian, Guangxia. Liang, Xing-Wang Zhu et al. · 0 citations
Open access Sep 2026

THE ROLE OF ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS AND TREATMENT OF SOLITARY LUNG LESIONS

The application of artificial intelligence is not limited to diagnosis and is expanding to the selection of follow-up intervals, automated detection of nodule growth, bronchoscopic navigation, surgical planning, and determination of treatment volumes in radiation therapy.

N. Nazarov · 0 citations
Open access Oct 2026

Detection and classification of thyroid diseases using ultrasound images through deep learning techniques

A two-stage deep learning-based model for automatic detection and classification of thyroid nodules in ultrasound images shows that segmentation with weak supervision along with classification using deep learning can provide efficient diagnosis of thyroid nodules even with minimal medical data annotation.

K. Subedi, Akash Yadav, Lochan Paudel · 0 citations
Review Sep 2026

Real-world Performance of Computer-aided Pulmonary Nodule Detection for Lung Cancer.

Vessel-suppressed images demonstrated high sensitivity for malignant pulmonary nodules, whereas CADe performance varied by nodule type and location, whereas CADe performance varied by nodule type and location.

Ariadne K. DeSimone, Kathryn A. Schulz, S. Byrne et al. · 0 citations
Open access Sep 2026

A malignancy risk prediction model for Bethesda category III thyroid nodules based on serological indicators, C-TIRADS, and BRAF V600E testing

Objective To investigate the diagnostic value of a multimodal prediction model integrating thyroglobulin antibody (TgAb), thyroid peroxidase antibody (TPOAb), the Chinese Thyroid Imaging Reporting and Data System (C-TIRADS), and BRAF V600E mutation status, for evaluating the malignancy risk in Bethesda Category III thy...

Wei Yang, C. Xiong, Shuang-Shuang Dong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.